FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lorazepam Injection, USP
Status: Currently in Shortage
»Date first posted: 05/03/2018
»Therapeutic Categories: Neurology

Expand all

Amphastar Pharmaceuticals, Inc./IMS (New 05/03/2018)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
LORAZEPAM INJECTION, USP, C IV [2 mg/ mL](NDC 76329-8261-1) Available Other

Hospira, Inc. (Revised 06/14/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4 mg/mL; Carpuject Luer Lock Glass Syringe (NDC 00409-1539-31) Next delivery and Estimated recovery: 2019 Shortage per manufacturer: Manufacturing Delay Other
2 mg/mL; Carpuject Luer Lock Glass Syringe (NDC 00409-1985-30) Next delivery: June 2018; Estimated Recovery: March 2019 Shortage per manufacturer: Manufacturing Delay

Dear Health Care Provider Letter

Other
2 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6778-02) Available Other
4 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6779-02) Next Delivery: June 2018; Estimated Recovery: December 2018 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
20 mg/10 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-6780-02) Next Delivery: September 2018; Estimated Recovery: December 2018 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English